Iterum Therapeutics plc
ITRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,774 | -$38,371 | -$44,434 | -$91,564 |
| Dep. & Amort. | $284 | $1,750 | $1,800 | $2,104 |
| Deferred Tax | $0 | $0 | $0 | $61,600 |
| Stock-Based Comp. | $363 | $784 | $22,108 | $4,319 |
| Change in WC | -$12,731 | $2,763 | $2,311 | -$440 |
| Other Non-Cash | $10,088 | -$6,256 | -$258 | $8,139 |
| Operating Cash Flow | -$26,770 | -$39,330 | -$18,473 | -$15,842 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$13 | -$62 | -$61 |
| Net Acquisitions | $0 | $0 | $0 | $55 |
| Inv. Purchases | -$12,390 | -$41,179 | -$45,708 | -$67,034 |
| Inv. Sales/Matur. | $30,600 | $64,528 | $59,727 | $12,500 |
| Other Inv. Act. | $0 | $0 | $0 | -$55 |
| Investing Cash Flow | $18,208 | $23,336 | $13,957 | -$54,595 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$2,251 | -$6,516 |
| Stock Issued | $26,691 | $1,034 | $433 | $89,643 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $26,691 | $1,034 | -$1,818 | $83,127 |
| Forex Effect | -$75 | -$61 | -$50 | $4 |
| Net Chg. in Cash | $18,054 | -$15,021 | -$6,384 | $12,694 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,105 | $21,092 | $27,510 | $14,816 |
| End Cash | $24,159 | $6,071 | $21,126 | $27,510 |
| Free Cash Flow | -$26,772 | -$39,343 | -$18,535 | -$15,903 |